OBJECTIVES:: HIV-infected patients have a greater burden of sub-clinical and clinical atherosclerotic disease compared to general population. The primary objective of this study was to compare the relative roles of inflammation, endothelial alterations, and metabolic factors in the induction and in the maintenance of atherosclerosis in antiretroviral therapy (ART)-treated or ART-naive patients. DESIGN:: Cross-sectional study;79 HIV-infected patients (55 ART-treated and 24 naive individuals) were consecutively enrolled. In both groups, nearly 50% of the individuals had a high cardiovascular risk (Framingham value >20%). METHODS:: Echo-Doppler (IMT), inflammatory, thrombophilic, endothelial, metabolic indexes, and cholesterol efflux molecules were evaluated. Multivariate analysis adjusted for age, CD4 nadir, BMIand Framingham's score were used to analyze the results. RESULTS:: A complex pathogenesis drives atherogenesis in HIV infection. Thus, whereas inflammation could be responsible for this process in ART-naive individuals, metabolic factors (LDL, ApoB, lipoprotein A) seem to play a more prevalent role in ART-treated patients. Notably, ABCA-1, an ATP-binding transporter cassette protein involved in cholesterol efflux which is inhibited by Nef, is up-regulated in ART treated individuals. CONCLUSIONS:: Atherosclerosis in HIV infection results from the interaction of multiple factors: an inflammatory- and HIV-driven disease could prevail in the absence of therapy; metabolic, non-inflammatory causes may be more important in patients undergoing therapy. Approaches to atherosclerotic disease in HIV infection should consider these differences

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or -treated individuals / S. Piconi, S. Parisotto, G. Rizzardini, S. Passerini, P. Meraviglia, M. Schiavini, F. Niero, M. Biasin, P. Bonfanti, E. Ricci, D. Trabattoni, M. Clerici. - In: AIDS. - ISSN 0269-9370. - 27:3(2013 Jan 28), pp. 381-389. [10.1097/QAD.0b013e32835abcc9]

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or -treated individuals

S. Piconi;S. Parisotto;S. Passerini;M. Biasin;BONFANTI, PAOLO;E. Ricci;D. Trabattoni;M. Clerici
2013-01-28

Abstract

OBJECTIVES:: HIV-infected patients have a greater burden of sub-clinical and clinical atherosclerotic disease compared to general population. The primary objective of this study was to compare the relative roles of inflammation, endothelial alterations, and metabolic factors in the induction and in the maintenance of atherosclerosis in antiretroviral therapy (ART)-treated or ART-naive patients. DESIGN:: Cross-sectional study;79 HIV-infected patients (55 ART-treated and 24 naive individuals) were consecutively enrolled. In both groups, nearly 50% of the individuals had a high cardiovascular risk (Framingham value >20%). METHODS:: Echo-Doppler (IMT), inflammatory, thrombophilic, endothelial, metabolic indexes, and cholesterol efflux molecules were evaluated. Multivariate analysis adjusted for age, CD4 nadir, BMIand Framingham's score were used to analyze the results. RESULTS:: A complex pathogenesis drives atherogenesis in HIV infection. Thus, whereas inflammation could be responsible for this process in ART-naive individuals, metabolic factors (LDL, ApoB, lipoprotein A) seem to play a more prevalent role in ART-treated patients. Notably, ABCA-1, an ATP-binding transporter cassette protein involved in cholesterol efflux which is inhibited by Nef, is up-regulated in ART treated individuals. CONCLUSIONS:: Atherosclerosis in HIV infection results from the interaction of multiple factors: an inflammatory- and HIV-driven disease could prevail in the absence of therapy; metabolic, non-inflammatory causes may be more important in patients undergoing therapy. Approaches to atherosclerotic disease in HIV infection should consider these differences
ABCA-1; ART; atherosclerosis; HIV; immunology
Settore MED/04 - Patologia Generale
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/210085
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 42
social impact